Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Invivyd, Inc. Director's Dealing 2021

Aug 6, 2021

33564_dirs_2021-08-05_05b834ac-124b-4e8e-abfc-9cdd400d0cf5.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Adagio Therapeutics, Inc. (ADGI)
CIK: 0001832038
Period of Report: 2021-08-05

Reporting Person: Russo Rene (Director)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 1985295 Direct